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Background: Podoconiosis is a lymphoedema of non-infectious cause which results in long-term ill health in
affected individuals. Simple, effective treatment is available in certain parts of Ethiopia, but evidence indicates that
not all patients continue collecting treatment supplies from clinic sites once started. We used qualitative techniques
to explore factors related to discontinued attendance at outreach clinics of a non-government organization in
southern Ethiopia.
Methods: A cross-sectional qualitative study was conducted in four clinic sites through unstructured in-depth
interviews, key informant interviews and focus group discussions with the involvement of 88 study subjects.
Results: Discontinuation of clinic visits is common among podoconiosis patients. The reasons were: remoteness
from the clinic sites, unrealistic expectation of ‘special’ aid, worry about increasing stigma, illness and
misconceptions about treatment.
Conclusions: Several of these factors are remediable through community and individual information and
education. Appropriate routes to deliver this information must be identified. Certain factors (such as distance
to clinic sites and stigma) require substantial expansion of services or liaison with village-level government
health services.
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Podoconiosis is a form of geochemical non-filarial ele-
phantiasis that results in bilateral lymphoedema of the
lower legs [1]. It is common among poor farmers who
have persistent barefoot contact with irritant red clay
soil rich in silicate particles [2]. Areas of high prevalence
of podoconiosis have been documented in tropical
Africa, Central America and north India [3]. Of affected
countries, Ethiopia appears to have the highest number
of people with podoconiosis [4], with 11 million people
at risk through exposure to irritant soil, and an esti-
mated 1 million people affected countrywide [5]. As the
disease progresses, patients become bedridden and
unable to work [5,6]. Long term ill health results in a
range of direct and indirect costs: medical and non* Correspondence: abezed@yahoo.com
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reproduction in any medium, provided the ormedical expenses; the opportunity cost of time seeking
healthcare; and the productivity cost of reduced working
days [6].
In spite of these huge social and economic costs,
podoconiosis remains relatively neglected in terms of
policy response or public health intervention at national
and international level [7]. Podoconiosis seems to be
neglected because it is non-communicable and causes
long term morbidity rather than mortality [5,8]. There is
no mention of podoconiosis in the Ethiopian govern-
ment’s 3rd or 4th Health Sector Development Plan
(HSDP-III or HSDP IV) [8], and as yet no provision of
prevention or treatment services through government
health facilities.
A local non-governmental organization, the Mossy
Foot Treatment and Prevention Association (MFTPA)
was established specifically to provide treatment and
care for patients with podoconiosis in Wolaita zone, and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lishment in 1998, thousands of patients from the locality
and surrounding zones have been treated at outreach
clinic sites [8]. Although outreach clinics that provide
health education and treatment to registered patients
are open on a weekly basis, any individual patient is
expected to attend only once per month for supervised
treatment and to collect treatment supplies [8]. The
clinic site health agents and social workers train patients
to self-manage lymphoedema through careful washing
with soap and water, use of an antiseptic, drying between
toes and folds, use of moisturizing or antiseptic cream
(e.g., Whitfield’s ointment), elastic bandaging in selected
patients, elevation of the leg, controlled exercise and use
of closed footwear and socks [8]. This regime has been
found to be effective in improving disease stage, leg
circumference and quality of life [9]. However, patients
with advanced stage disease may not exhibit improve-
ment overnight; lifetime care and treatment are import-
ant to control the progress of the disease and other
complications [10].
Anecdotal evidence from clinic registers suggests that
a proportion of registered patients with podoconiosis
do not continue collecting treatment supplies from out-
reach clinics having started. Studies indicate that poor
adherence to appropriate medication therapy for chronic
conditions results in complications and increased health
care costs [11,12]. In developing countries, like Ethiopia,
when poor access to health care, possible lack of diagno-
sis, and limited availability of medications are taken into
account, poor adherence threatens efforts to treat
chronic conditions [13]. Complex socioeconomic, demo-
graphic and psychological factors have been reported in
various studies as affecting adherence to medication
therapy of chronic diseases [14-17]. According to Wood,
the first step to overcome adherence challenges is to iden-
tify factors that prevent adherence [11]. Yet, no studies
have been carried out to identify factors related to discon-
tinued collection of treatment supplies by podoconiosis
patients in Ethiopia. We therefore aimed to explore fac-
tors related to discontinued attendance at treatment and
prevention clinics by patients with podoconiosis.
Methods
Ethics considerations
The study participants were recruited once they were
fully aware of the purpose of the study and the methods
of data collection. They were asked to provide witnessed
oral consent to participation in the study. No written
consent was asked for fear this might bias the interview
process as most of the study subjects were illiterate [18].
Consent was witnessed by at least one person other than
the principal investigator. For children under the age of
18, parents were asked to provide oral consent. Potentialparticipants were clearly informed that they had a right
to stop the interview at any time or to skip questions
they did not want to answer. They were also told
that interviews would be held in a private place and
that identifiable data would not be viewed by any third
party. Permission was also gained from the MFTPA
since all of the study subjects were approached through
the organization’s outreach clinics. The scientific com-
mittee in College of Social Sciences in Addis Ababa
University approved the study based on the above
ethical considerations.
Study area
The study was conducted in Wolaita zone, southern
Ethiopia, located 385kms from Addis Ababa, the capital
of Ethiopia. Wolaita is one of the most densely popu-
lated areas in Ethiopia with an estimated total popula-
tion of 1.7 million in 2007[19]. Most people earn their
living from subsistence agriculture, and high prevalence
of podoconiosis has been documented in this area [2].
The Mossy Foot Treatment and Prevention Association
(MFTPA) offers community-based prevention and treat-
ment at 15 outreach sites located 15 to 65km from the
headquarters in Sodo town. Treatment supplies are
offered every month free or for a small fee (2 Birr, £0.08
or $0.12).
Study design and sampling
We conducted a qualitative study using in-depth-
interviews (IDIs), focus group discussions (FGDs) and
key informant interviews (KIIs). Four of fifteen clinic
sites of the Mossy Foot Treatment and Prevention Asso-
ciation (MFTPA) were purposively selected to include a
wide range of patient follow-up durations.
We employed theoretical sampling techniques to
recruit study subjects into In-depth Interviews (IDI) and
Focus Group Discussions (FGD). Forty-four podoconio-
sis patients took part in In-Depth Interviews. People
who came to the clinic sites for purposes other than col-
lecting treatment supplies were excluded. The MFTPA
project director and social work department head parti-
cipated in Key Informant interviews as they have estab-
lished extensive relationships with the patients. Having
identified FGD participants with the help of clinic site
staff, we grouped them into three categories: community
and religious leaders, podoconiosis patients, and clinic
site health agents and social workers. Two FGDs with
male community and religious leaders, three FGDs with
podoconiosis patients (one for women only, two mixed),
and two FGDs with female and male clinic site health
agents and social workers were held. Each group was
composed of six participants giving a total of forty
two participants. Data collection continued until no new
information emerged through further interviews.
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Data collection was conducted over a four week period
in March 2010 by AT (a native speaker of the local lan-
guage, Wolaitigna). Three types of unstructured and
pilot tested interview guides were used to conduct Focus
Group Discussions (FGDs), Key Informant Interviews
(KIIs), and In-depth interviews (IDIs). In-depth inter-
view informants were approached on the days scheduled
for clinic visits and asked to indicate whether they had
missed a visit at least once since their first visit. Each
month, each patient needs to attend clinic for education
and treatment supplies. We therefore defined any pa-
tient not attending clinic on one or more scheduled oc-
casion(s) as non-adherent. Those who had missed
collecting treatment supplies were interviewed to estab-
lish what factors might have contributed. Clinic site
staff arranged a private setting where interviews were
held with each informant for about 20 to 30 minutes.
Information obtained through in-depth interviews was
complemented by key informant interviews and focus
group discussions. Focus group discussion participants
were asked why they thought patients might not con-
sistently attend clinic, while key informants and clinic
site health agents were also asked how consistent
patients were in collecting treatment. Discussions in all
focus groups were held in neighboring homes where
only the recruited participants gathered for about 1
and half hours. An experienced note-taker was hired
to take notes during individual interviews and focus
group discussions. Audio recording was also used with
prior consent of the informants. A unique identifying
number was given to all informants in advance to
link the data obtained through interviews and focus
group discussions.
Data analysis
AT transcribed field notes and audio files of interviews
and focus group discussions in the local languages (both
Amharic and Wolaitigna) used during data collection
and checked for accuracy through replay of cassettes
and revision of field notes. Unique identifying numbers
and demographic variables assigned to each informant
during data collection were linked to the data during
transcription and names of specific people mentioned in
the data were removed. A meaning based translation of
transcripts was made by AT and GT. The text data typed
into the word file were organized using manual coding
techniques to code and categorize similar ideas. To in-
crease the validity of coding, three coders were involved
to organize the data based on themes of interview guides
and themes derived from the data. The coders resolved
overlapping themes and inconsistencies in data sources
through regular meetings, and incorporated additional
themes suggested in the discussion.In the coding process, informants who had missed
collecting treatment supplies were categorized as ‘irregu-
lar visitors’ for the purpose of further analysis. It has been
suggested that identification of non-adherent patients is
of particular importance because they represent the high-
est priority target of intervention strategies [20]. Themes
identified in interviews and focus group discussions
through questions about reasons for irregular visits were
categorized as determinants of discontinued attendance.
Results
Eighty-eight participants were included; forty male and
forty-eight female. Participants were aged between 16
and 75 years. The following factors appeared to be
related to discontinuation of clinic visits among podoco-
niosis patients.
Remoteness from the clinic site
Distance of clinic sites from patients’ homes, coupled
with physical disability and difficulty finding and afford-
ing transport, are prime reasons for non-adherence.
I began treatment when it was being provided in a
town named Badesa. It took me three hours on foot to
get there. I tried to visit the clinic for some time but
stopped when my feet developed wounds [In-depth
interview informant, a 30 year old female patient].
According to some FGD participants, there are no
modern forms of transport in the villages in which
podoconiosis patients live. Patients living in such areas
are forced to walk long distances on foot, making
attendance very difficult.
There are villages where there are no means of
transport. The only alternative for patients in such
areas is to walk on foot. But, to walk long distances for
a podoconiosis patient is challenging. Thus, some
patients refrain from visiting the clinic sites located far
from their residence [FGD participant, religious
leader, 30 years].
Even if transport is available, patients may be unable
to afford it.
I sometimes postpone visiting the clinic when I have
no money for transport. I avoid walking on foot fearing
wounds that may develop. When I walk, my foot
immediately develops wounds, so I remain at home
in such conditions [In-depth interview informant, 16
years].
Some of the FGD participants thought the problem of
distance was even greater for older patients.
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find it difficult to walk long distances. Some older
patients send their children or other individuals to
the clinics [FGD participant, 50 years].
Responses from the study subjects indicate that the
existing services are not accessible enough to patients
living in remote places. Several stated that expansion of
services to remote rural villages was likely to improve
clinic attendance.
Expectations of ‘special’ support
MFTPA staff thought that some patients came to the
clinic sites expecting aid in the form of material or
financial benefits other than treatment supplies from
the organization. Such patients visit the clinic once or
twice and stop after realizing that there is nothing ‘spe-
cial’ beyond the treatment program.
Some patients think that they deserve special support
just because they are patients. Such patients stop
visiting the clinic after realizing that there is no
special benefit. They don’t even consider that they
are getting the treatment for their own health [FGD
participant, clinic site health agent, 34 years].
The misconception that other patients who make regu-
lar visits get special benefits from the non-government
organization is a ‘pull’ factor for some. Patients who
begin with these misconceptions soon stop once they
realize that there is no special advantage.
Once, I approached a podoconiosis patient who had
stopped receiving clinic treatment. I asked him to
begin treatment again. He replied ‘You wouldn’t knock
at everybody’s door unless you received some special
privilege in our name’. I was shocked when the man
reacted in such a way [FGD participant, clinic site
social worker, 28 years].
Seeking special aid becomes particularly common
among patients during times of drought or famine. At
these times, patients fail to make regular clinic visits.
According to the MFTPA Social Work Department
head, patients openly ask the organization to provide
them food and other forms of aid in such hard times.
Patients expect something from the organization
during drought and famine. During these seasons it
is quite difficult to provide only treatment supplies
while patients are literally suffering from starvation.
As providing food items and other aids is not the
role of this organization, some patients abandon
visiting the clinics until they pass those hard times[Key informant, head of MFTPA’s social work
department].
Worry about increasing stigma
Podoconiosis patients are deterred from seeking treat-
ment because they fear this will reinforce stigma
against them. Since the clinics at which treatment is
offered are for podoconiosis patients only, some
patients fear that attendance will identify them as hav-
ing the disease.
I was making house visits that day. I heard that
there was a child who had stopped attending the
clinic because his parents did not wish him to
attend. I asked his parents why they prevented the
child from visiting the clinic. Their immediate
response was ‘there is nobody sick in our home’.
What I understood from their response is that they
feared being identified as having a podoconiosis
patient in their family [FGD participant, community
leader, 32 years].
Worry about increasing stigma also affects the health
seeking behavior of patients with early manifestations.
Patients with early manifestations avoid visiting the
clinic sites in order to avoid public identification. These
patients do not want to be identified as having podoco-
niosis. In the early stages, they hide their feet by wearing
long clothes and shoes, and only start seeking treatment
once the swelling becomes difficult to disguise.
When we tell some patients with early manifestations
of podoconiosis to come to clinic, they respond
abruptly that they are not sick. They don’t like to be
pointed out as “gedya kita” [local name for a swollen
foot]. I know a lot of patients who neglected our
warnings but later started to receive treatment after
the swelling had progressed to more advanced
stages [FGD participant, clinic site health agent,
30 years].
Some family members prevented children or other
dependents from using the treatment supplies they col-
lected from the MFTPA outreach clinics because of the
discomfort they feel about the smell.
I live with my aunt. Once, she said ‘all your feet,
your shoes, and the medicine you use are stinky’.
It suffocates the house. She thought it is a big
humiliation when people enter the house. She
then threw both my shoes and the bleach
outside. As a result, I was discouraged to receive
treatment kits [In-depth interview informant,
18 years].
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Recurrent illness prevents patients from attending clinic
regularly. Patients become ill with acute adenolymphan-
gitis (ALA): attacks of fever, pain and increased swelling
of the leg related to super-infection, physical injuries
or strenuous activity. During such an attack they may
become bedridden for days or even weeks. Conse-
quently, they cannot attend clinic and thus do not col-
lect supplies necessary for treatment.
I remember it was when I was coming from the
market. I went to the market to sell something. It was
very hot and sunny. I was standing long hours in that
situation. Finally, when I was coming home I fell down
in the middle of the road. People gathered together,
carried me and took me to my home. I was completely
unconscious when all that happened. I stayed on bed
for weeks until I recovered [FGD participant, clinic
site health agent, 32 years].
Walking long distances and working long hours on the
farm is not good. It brings big swelling in ‘ankakuleta’
[a local name for swelling of lymph nodes] and blocks
any movement, and then brings headache and
shivering. The illness may stay for weeks and prevent
collection of treatment supplies [In-depth interview
informant, 35 years].
Injuries of the foot also cause illness to the patient.
A 28 year old in-depth interview informant indicated
why he could not consistently collect treatment supplies.
I missed clinic for four consecutive months. I was cut
by a sharp thing while I was working on the farm. It
took four months for me to recover. At that time I had
no-body to send to the clinic to bring the treatment
kits. The pain and the swelling worsened.
Misconceptions about treatment
According to FGD participants, patients with podoco-
niosis make great efforts (using both traditional and
modern forms of treatment) to treat their feet. If, despite
their effort and expense, they do not see improvement
using one form of treatment, some doubt that any treat-
ment will be effective. According to a FGD participant,
There is a person who I know in my village. He has
been suffering from the disease for many years. He
went to many places looking for holy water and went
to several hospitals, but did not see any improvement.
His foot was getting worse whatever he did. Once,
I informed him about the podoconiosis treatment.
But, he would not believe that his foot might recover.
After repeated visits to his home to tell him about thetreatment, I managed to bring him to the clinic site
so that he saw some improvement after consistent
follow-up [FGD participant, 42 years].
Failure to experience immediate improvement after
receiving podoconiosis treatment may also make some
patients stop attending. Some in-depth interview infor-
mants indicated that they had stopped visiting the clinics
thinking that the treatment was not effective.
I stopped going to the clinic site when I couldn’t see
any improvement. I was eager to get normal feet back.
But it did not happen. But the condition of my foot
deteriorated after I stopped receiving treatment
supplies [In-depth interview informant, 22 years].
Even though patients are consistently advised that they
need to stick with the lymphoedema treatment regimen,
some patients still discontinue treatment. According to a
clinic site agent, “most patients come to the clinic sites
expecting to get immediate relief, so they become disap-
pointed and stop receiving treatment when they fail to
experience improvement”.
In contrast, there are also some podoconiosis patients
who experience improvement soon after starting treat-
ment. Such patients think their feet are healthy again,
and stop attending. They may only restart treatment
when their feet deteriorate and develop increased swel-
ling, wounds, or mossy changes.
I stopped taking the treatment kits thinking that
my foot was cured. After four months without
treatment, my foot started to swell up again. I started
the treatment again after I experienced further
complications [In-depth interview informant,
30 years].
Such patients are misled by the improvement they
experience after following treatment for a short time.
The clinic site agents stated that they repeatedly warn
the patients not to stop treatment irrespective of
improvement as the disease may progress due to further
exposure to the environmental trigger. According to the
clinic site health agent,
Some patients come to the clinic site when they
get sick but stop after seeing some improvement.
We teach them not to quit the treatment by stressing
that the disease needs lifelong care and treatment.
[FGD participant, 34 years].
Discussion
In Wolaita zone where over 5% of the total popula-
tion is estimated to have lymphoedema secondary to
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cation on lymphoedema management and treatment
supplies. The MFTPA uses a model of community-based
care led by expert patients and supported by community
Network Groups [8]. Even though recent work in north-
ern Nigeria [21] identified a similar model (community-
selected and supported care-givers) as the most effective
in reducing lymphoedema and adenolymphangitis
episodes, it has been clear in Wolaita that not all podo-
coniosis patients continue treatment. We discuss here
some of the factors that appear to reduce patients’
adherence with attending a clinic to collect podoconiosis
treatment supplies. Five key factors were identified:
distance to the clinic sites, unrealistic expectation of
‘special’ aid, worry about increasing stigma, illness,
and misconceptions about treatment. However, as a
qualitative study, our aim was exploratory, and we
could not measure the variation in influence of these
factors by sociodemographic characteristics or level of
disease severity.
First, the locations of the MFTPA clinics may be in-
accessible for patients who live in remote rural villages.
Most clinics are located in small towns, while the large
majority of podoconiosis patients are from the surround-
ing rural areas [2,5,8]. These areas often lack means of
transport, so patients are forced to walk long distances
on foot, which is challenging because of the disability
caused by their foot swelling. Even if there is transport,
it may be unaffordable to patients. Similar barriers have
been described in relation to treatment for lymphatic
filariasis (LF) in northern Nigeria [21] and in Kenya [22].
While it may be impossible for a small NGO like
MFTPA to increase accessibility through expansion,
linking podoconiosis treatment with government ser-
vices delivered at village level may improve accessibility
for patients.
Second, as most patients with podoconiosis are very
poor rural farmers [1,7] whose disease has exacerbated
their poverty [6], they will naturally look for other forms
of support in addition to treatment. In this study, we
found that some podoconiosis patients discontinue col-
lecting treatment supplies, particularly during drought
or famine, because they are not offered financial or ma-
terial support other than treatment supplies. This may
be because most Non-Governmental Organization
(NGOs) working in rural areas have broader develop-
ment aims than the MFTPA which focuses on control of
one specific disease. Many podoconiosis patients may
have experience of receiving more direct financial or
other forms of support, creating unrealistic expectations
of what the MFTPA might offer. The MFTPA must
improve community awareness of its specific role in
podoconiosis control, and increase collaboration with
other agencies so that patients requiring other forms ofassistance can be referred appropriately. Other govern-
mental and non-governmental organizations should
be invited to engage in (re)building the livelihoods of
such patients.
Third, perceived stigma from family members or the
wider community is a serious barrier to adherence with
collecting clinic based lymphoedema treatment supplies,
and is manifested in avoidance of the treatment clinics
as a coping strategy [23]. Provision of treatment supplies
through MFTPA clinics, which the public know are for
podoconiosis patients only, generates deep fear of identi-
fication among patients. Patients in the early stages of
disease who disguise it find this particularly difficult, and
may either completely avoid the clinics, or may start col-
lecting treatment supplies and then stop. A study on
lymphatic filariasis showed that perceived stigma was an
important issue in causing delay in diagnosis and treat-
ment of patients [24]. Studies on determinants of adher-
ence of people living with HIV to Antiretroviral
Treatment (ART) also confirm that lack of social sup-
port and discrimination by family members contribute
for dropout of treatment despite improved health and
interest of the patient [14-16]. Integration of podoconio-
sis treatment with other primary health care services
may be effective in tackling stigma related to accessing
treatment from existing vertical or stand-alone program.
Fourth, although lymphoedema care reduces acute
adenolymphangitis episodes in LF [21] and anecdotally
also in podoconiosis, if these episodes occur despite
treatment, they may themselves prevent patients attend-
ing clinic for treatment and further supplies. Adenolym-
phangitis may be triggered by circumstances such as
strenuous activity, walking long distances, and cold
or rainy seasons. More flexible systems for distribution
of treatment supplies may be necessary to take into
account patients who develop acute illness and are
unable to attend clinic.
Fifth, some podoconiosis patients stop collecting
supplies because of misconceptions about the treat-
ment regimen. While some discontinue because of the
assumption that the treatment is not working, others
stop because they feel healthy after receiving treatment
for some time. Once patients reach the advanced stages
of podoconiosis, many of the changes that have occurred
are irreversible [18]. Treatment prevents further pro-
gression and diminishes episodes of acute adenolym-
phangitis [9], but will not achieve reversal of all the
swelling and dermal overgrowth that are prominent
in late stage disease [10]. Discontinuation because of
disappointment in results was also reported in LF treat-
ment study [21]. The more advanced the stage of
disease, the more likely patients are to doubt the
effectiveness of treatment since improvement is rarely
experienced. Conversely, some podoconiosis patients
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experience substantial improvement in the condition of
their feet.
Conclusion
In conclusion, this study has identified a range of factors
that determine adherence of patients with collecting
treatment supplies from MFTPA clinics. Some of these
factors can be overcome with relatively simple measures:
improving patient understanding of the need for lifelong
treatment; better informing patients about the likely
outcomes of podoconiosis treatment; and convincing
patients of the need to prioritize treatment over other
activities. Reducing distance to a clinic or supply distri-
bution point will require linking MFTPA services with
government health schemes in villages, and reducing
community stigma against patients will require a multi-
agency approach and considerable time.
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